In a report released today, Bob Brackett from Bernstein maintained a Buy rating on Glencore (GLEN – Research Report), with a price target of ...

Novo Nordisk shares rose Monday as the company said it would present new data on the ability of semaglutide, the active ingredient in its weight-loss drugs Ozempic and Wegovy, to lower heart risks.

Assetmark Inc. boosted its position in shares of Corning Incorporated (NYSE:GLW – Free Report) by 101.5% during the 4th ...

RBC Capital analyst Ben Davis maintained a Buy rating on Glencore (GLEN – Research Report) yesterday and set a price target of p440.00. The ...

Homegrown pharmaceutical companies launching significantly cheaper generic versions of empagliflozin—a widely prescribed SGLT2 inhibitor for type-2 diabetes ...

Prices of key anti-diabetic drug empagliflozin crashed by as much as 90 per cent to ₹5.5 per tablet as several pharma ...

Glenmark and Alkem Labs launched the generic version as well as its Fixed Dose Combination (FDCs) of Empagliflozin in India.

According to Krishan, the stock is a 'buy' at the current level, with a target price of Rs 640 and a stop loss of Rs 595. It ...

New Delhi: Cancer patients facing prohibitive treatment costs in India can hope for relief: the nation's top drugmakers have ...

Glenmark Pharmaceuticals on Monday, March 3, announced the acquisition and launch of Acetylcysteine injection in the United States by its subsidiary. This new product will be available in the strength ...

Glenmark Pharmaceuticals is recalling close to 15 lakh bottles of a generic medication used in the treatment of attention deficit hyperactivity disorder in the U.S. market, according to the U.S ...